These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9385624)

  • 1. Acute administration of phenylpropanolamine fails to affect resting energy expenditure in men of normal weight.
    Rushing PA; Winders SE; Watson SL; Klesges RC
    Obes Res; 1997 Sep; 5(5):470-3. PubMed ID: 9385624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phenylpropanolamine on energy expenditure and weight loss in overweight women.
    Alger S; Larson K; Boyce VL; Seagle H; Fontvieille AM; Ferraro RT; Rising R; Ravussin E
    Am J Clin Nutr; 1993 Feb; 57(2):120-6. PubMed ID: 8424378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies with phenylpropanolamine: a metaanalysis.
    Greenway FL
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):203S-205S. PubMed ID: 1530830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the pressor effect of phenylpropanolamine in healthy subjects.
    Blackburn GL; Morgan JP; Lavin PT; Noble R; Funderburk FR; Istfan N
    JAMA; 1989 Jun; 261(22):3267-72. PubMed ID: 2716162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the anorectic drug, phenylpropanolamine, on blood glucose in rats.
    Resnick SI; Hernandez L; Chen J; Hoebel BG
    Pharmacology; 1978; 17(3):157-62. PubMed ID: 704658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylpropanolamine and blood pressure: a review of prospective studies.
    Morgan JP; Funderburk FR
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):206S-210S. PubMed ID: 1728835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effects of phenylpropanolamine on appetite and food intake.
    Caffry EW; Kissileff HR; Thornton JC
    Pharmacol Biochem Behav; 1987 Feb; 26(2):321-5. PubMed ID: 3575355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in blood pressure following escalating doses of phenylpropanolamine and a suggested protocol for monitoring.
    Segev G; Westropp JL; Kulik C; Lavy E
    Can Vet J; 2015 Jan; 56(1):39-43. PubMed ID: 25565712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phenylpropanolamine and isometric exercise on blood pressure.
    Pentel PR; Eisen T
    Int J Obes; 1988; 12(3):199-204. PubMed ID: 3391736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a combination of herbs on appetite suppression and weight loss in rats.
    Talpur NA; Echard BW; Manohar V; Preuss HG
    Diabetes Obes Metab; 2001 Jun; 3(3):181-5. PubMed ID: 11412282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females.
    Walsh KM; Leen E; Lean ME
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1009-15. PubMed ID: 10557020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic doses of phenylpropanolamine increase supine systolic blood pressure.
    Pentel PR; Aaron C; Paya C
    Int J Obes; 1985; 9(2):115-9. PubMed ID: 4030197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phenylpropanolamine on withdrawal symptoms.
    Klesges RC; Klesges LM; DeBon M; Shelton ML; Isbell TR; Klem ML
    Psychopharmacology (Berl); 1995 May; 119(1):85-91. PubMed ID: 7675954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations.
    Horowitz JD; Lang WJ; Howes LG; Fennessy MR; Christophidis N; Rand MJ; Louis WJ
    Lancet; 1980 Jan; 1(8159):60-1. PubMed ID: 6153233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion?
    Swain RA; Harsha DM; Baenziger J; Saywell RM
    Clin J Sport Med; 1997 Jul; 7(3):168-73. PubMed ID: 9262882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of multiple doses of phenylpropanolamine on the blood pressure of patients whose hypertension was controlled with beta blockers.
    O'Connell MB; Gross CR
    Pharmacotherapy; 1991; 11(5):376-81. PubMed ID: 1684039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
    Greenway F; Herber D; Raum W; Herber D; Morales S
    Obes Res; 1999 Jul; 7(4):370-8. PubMed ID: 10440593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects.
    Graf P; Toll K; Palm J; Hallén H
    Acta Otolaryngol; 1999; 119(7):837-42. PubMed ID: 10687944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction.
    Hansen DL; Toubro S; Stock MJ; Macdonald IA; Astrup A
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1016-24. PubMed ID: 10557021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sibutramine on resting metabolic rate and weight loss in overweight women.
    Seagle HM; Bessesen DH; Hill JO
    Obes Res; 1998 Mar; 6(2):115-21. PubMed ID: 9545017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.